Saint Vincent Okays Psychedelic Initiative
The Caribbean country of Saint Vincent and the Grenadines has approved an initiative to incentivize psychedelic research and wellness.
The small English-speaking island nation, located about 100 miles north of Venezuela’s coast, has passed a measure that will allow for the “cultivation, research, processing, and prescription of psychedelic plant-based compounds including psilocybin, ibogaine, peyote, ketamine, dimethyltryptamine, ayahuasca and sassafras."
Much like Jamaica, Saint Vincent could become a hub for psychedelic research and psychedelic-assisted therapy clinics, leading to a possible trend of psychedelic retreats in the Caribbean region.
The initiative spun off a willingness to explore the possibilities offered by the country’s vast flora, which includes naturally-occurring psychedelic plants and fungi.
The country has granted three licenses so far to SVG Biomed, Mera Life Sciences and Ajori Health & Wellness. The psychedelic therapy program will be available to people from all nationalities and clinics will be regulated similarly to those in Canada and the United States, said a spokesperson for the SVG Bureau of Standards.
Delic Corp. To Go Public On The CSE
E-commerce and events company Delic Corp., which is focused on the psychedelics industry, announced last week it would be going public on the Canadian Securities Exchange via a reverse takeover (RTO) of Molystar Resources Inc.
Delic was formed in 2019 as an umbrella media platform. It currently includes three subsidiary companies: an e-commerce lifestyle brand named The …